Abstract

While the precise processes underlying a sex bias in the development of central nervous system (CNS) disorders are unknown, there is growing evidence that an early life immune activation can contribute to the disease pathogenesis. When we mimicked an early systemic viral infection or applied murine cytomegalovirus (MCMV) systemically in neonatal female and male mice, only male adolescent mice presented behavioral deficits, including reduced social behavior and cognition. This was paralleled by an increased amount of infiltrating T cells in the brain parenchyma, enhanced interferon-γ (IFNγ) signaling, and epigenetic reprogramming of microglial cells. These microglial cells showed increased phagocytic activity, which resulted in abnormal loss of excitatory synapses within the hippocampal brain region. None of these alterations were seen in female adolescent mice. Our findings underscore the early postnatal period’s susceptibility to cause sex-dependent long-term CNS deficiencies following infections.

Early life inflammation has been linked to neurodevelopmental outcomes. Here the authors show that in mice, neonatal immune challenge results in CD3 + T cell infiltration to brain parenchyma, and microglial activation, to a greater extent in males than females.

Details

Title
Neonatal immune challenge poses a sex-specific risk for epigenetic microglial reprogramming and behavioral impairment
Author
Schwabenland, Marius 1   VIAFID ORCID Logo  ; Mossad, Omar 2   VIAFID ORCID Logo  ; Sievert, Annika 1 ; Peres, Adam G. 1 ; Ringel, Elena 1 ; Baasch, Sebastian 3   VIAFID ORCID Logo  ; Kolter, Julia 3 ; Cascone, Giulia 1 ; Dokalis, Nikolaos 2 ; Vlachos, Andreas 4 ; Ruzsics, Zsolt 5   VIAFID ORCID Logo  ; Henneke, Philipp 6   VIAFID ORCID Logo  ; Prinz, Marco 7   VIAFID ORCID Logo  ; Blank, Thomas 1   VIAFID ORCID Logo 

 University of Freiburg, Institute of Neuropathology, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9) 
 University of Freiburg, Institute of Neuropathology, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Faculty of Biology, Freiburg, Germany (GRID:grid.5963.9) 
 University of Freiburg, Faculty of Medicine, University of Freiburg, Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center, Freiburg, Germany (GRID:grid.5963.9) 
 University of Freiburg, Department of Neuroanatomy, Institute of Anatomy and Cell Biology, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Center for Basics in Neuromodulation (NeuroModulBasics), Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9) 
 University of Freiburg, Institute for Virology, Faculty of Medicine, Medical Center, Freiburg, Germany (GRID:grid.5963.9) 
 University of Freiburg, Faculty of Medicine, University of Freiburg, Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Faculty of Medicine, University of Freiburg, Center for Pediatrics and Adolescent Medicine, Medical Center, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, CIBSS Centre for Integrative Biological Signalling Studies, Freiburg, Germany (GRID:grid.5963.9) 
 University of Freiburg, Institute of Neuropathology, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Center for Basics in Neuromodulation (NeuroModulBasics), Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Signalling Research Centres BIOSS and CIBSS-Centre for Integrative Biological Signalling Studies, Freiburg, Germany (GRID:grid.5963.9) 
Pages
2721
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2812329342
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.